Further study of CD31 protein and messenger ribonucleic acid expression in human cerebral vascular malformations

Neurosurgery

Volumn 50, Issue 1, 2002, Pages 110-115

  Uranishi, Ryunosuke ^a   Awadallah, Nabil A ^a   Ogunshola, Omolara O ^a   Awad, Issam A ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Arteriovenous malformations; Brain; Cavernous malformations; CD31; Immunohistochemistry; In situ hybridization

Indexed keywords

CD31 ANTIGEN; MESSENGER RNA; VON WILLEBRAND FACTOR;

ARTICLE; BRAIN ARTERIOVENOUS MALFORMATION; CEREBROVASCULAR MALFORMATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; ADOLESCENT; ADULT; BRAIN ARTERY; BRAIN CORTEX; BRAIN TUMOR; CAVERNOUS HEMANGIOMA; ENZYME IMMUNOASSAY; FEMALE; GENE EXPRESSION; GENETICS; MALE; MESENCEPHALON; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; REFERENCE VALUE;

ADOLESCENT; ADULT; ANTIGENS, CD31; BRAIN NEOPLASMS; CEREBRAL ARTERIES; CEREBRAL CORTEX; FEMALE; GENE EXPRESSION; HEMANGIOMA, CAVERNOUS; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; MALE; MESENCEPHALON; MIDDLE AGED; REFERENCE VALUES; RNA, MESSENGER;

EID: 0036364031     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-200201000-00019     Document Type: Article

References (33)

1. Abdulrauf SI, Kaynar MY, Awad IA: A comparison of the clinical profile of cavernous malformations with and without associated venous malformations. Neurosurgery 44:41-46, 1999.
2. Albelda SM, Muller WM, Buck CA, Newman PJ: Molecular and cellular properties of PECAM-1 (endoCAM/CD31): A novel vascular cell adhesion molecule. J Cell Biol 114:1059-1067, 1992.
3. Albelda SM, Oliver PD, Romer LH, Buck CA: Endo-CAM: A novel endothelial cell-cell adhesion molecule. J Cell Biol 110: 1227-1237, 1990.
4. Aroca F, Renaud W, Bartoli C, Bouvier-Labit C, Figarella-Branger D: Expression of PECAM-1/CD31 isoforms in human brain tumors. J Neurooncol 43:19-25, 1999.
5. Bhan AK: Immunoperoxidase, in Colvin RB, Bhan AK, McCluskey RT (eds): Diagnostic Immunopathology. New York, Raven Press, 1995, ed 2, pp 711-723.
6. Bischoff J: Approaches to studying cell adhesion molecules in angiogenesis. Trends Cell Biol 5:69-74, 1995.
7. Brown RD Jr: Epidemiology and natural history of vascular malformations of the central nervous system, in Jafar JJ, Awad IA, Rosenwasser RH (eds): Vascular Malformations of the Central Nervous System. Philadelphia, Lippincott Williams & Wilkins, 1999, pp 129-148.
8. 3 as a heterotypic ligand for CD31/PECAM-1. J Cell Sci 109:437-445, 1996.
9. Delisser HM, Christofidou-Solomidou M, Strieter RM, Burdick MD, Robinson CS, Wexler RS, Kerr JS, Garlanda C, Merwin JR, Madri JA, Albelda SM: Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol 151:671-677, 1997.
10. Delisser HM, Newman PJ, Albeda SM: Molecular and functional aspects of PECAM-1/CD31. Immunol Today 15:490-495, 1994.
11. Gunel M, Awad IA, Finberg K, Steinberg GK, Craig HD, Cepeda O, Nelson-Williams C, Lifton RP: Genetic heterogeneity of inherited cerebral cavernous malformations. Neurosurgery 38:1265-1271, 1996.
12. Hashimoto T, Emala CW, Joshi S, Mesa-Tejada R, Quick CM, Feng L, Libow A, Marchuk DA, Young WL: Abnormal pattern of Tie-2 and vascular endothelial growth factor receptor expression in human cerebral arteriovenous malformations. Neurosurgery 47: 910-919, 2000.
13. Hatva E, Jääskeläinen J, Hirvonen H, Alitalo K, Haltia M: Tie endothelial cell-specific receptor tyrosine kinase is upregulated in the vasculature of arteriovenous malformations. J Neuropathol Exp Neurol 55:1124-1133, 1996.
14. Horak ER, Leek R, Klenk N, Lejeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris AL: Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340:1120-1124, 1992.
15. Kiliç T, Pamir MN, Küllü S, Eren F, Ozek MM, Black PMcL: Expression of structural proteins and angiogenic factors in cerebrovascular anomalies. Neurosurgery 46:1179-1192, 2000.
16. Kim CS, Wang T, Madri JA: Platelet endothelial cell adhesion molecule-1 expression modulates endothelial cell migration in vitro. Lab Invest 78:583-590, 1998.
17. Matsumura T, Wolff K, Petzelbauer P: Endothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin. J Immunol 158:3408-3416, 1997.
18. Muller WA: CD31 workshop panel report, in Kishimoto T, Kikitani H, von dem Borne AE, Goyert SM, Mason DY, Miyasaka M, Moretta L, Okumura K, Shaw S, Springer TA, Sugamura K, Zola H (eds): Leukocyte Typing VI. New York, Garland Publishing, Inc., 1997, pp 362-364.
19. Muller WA, Ratti CM, McDonnell SL, Cohn ZA: A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions. J Exp Med 170:399-414, 1989.
20. Muller WA, Weigl SA, Deng X, Phillips DM: PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 178:449-160, 1993.
21. Ogunshola OO, Stewart WB, Mihalcik V, Solli T, Madri JA, Ment LR: Neuronal VEGF expression correlates with angiogenesis in postnatal developing rat brain. Dev Brain Res 119:139-153, 2000.
22. Parums DV, Cordell JL, Micklem K, Heryet AR, Gatter KC, Mason DY: JC70: A new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol 43:752-757, 1990.
23. 3 integrin involved in adhesion of leukocytes to endothelium. J Cell Biol 130:451-460, 1995.
24. Prager E, Sunder-Plassmann R, Hansmann C, Koch C, Holter W, Knapp W, Stockinger H: Interaction of CD31 with a heterophilic counterreceptor involved in downregulation of human T cell responses. J Exp Med 184:41-50, 1996.
25. Rothbart D, Awad IA, Lee J, Kim J, Harbaugh R, Criscuolo GR: Expression of angiogenic factors and structural proteins in central nervous system vascular malformations. Neurosurgery 38:915-925, 1996.
26. Taylor CR, Hofman FM, Modlin RL, Rea TH: Immunoperoxidase techniques applied to dermatopathology. J Cutan Pathol 10:145-163, 1983.
27. Uranishi R, Baev NI, Ng PY, Kim JH, Awad IA: Expression of endothelial cell angiogenesis receptors in human cerebral vascular malformations. Neurosurgery 48:359-368, 2001.
28. Watt SM, Gschmeissner SE, Bates PA: PECAM-1: Its expression and function as a cell adhesion molecule on hemopoietic and endothelial cells. Leuk Lymphoma 17:229-236, 1995.
29. + hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes. Blood 82:2649-2663, 1993.
30. Wautier MP, Boval B, Chappey O, Enjolras O, Wernert N, Merland JJ, Wautier JL: Cultured endothelial cells from human arteriovenous malformations have defective growth regulation. Blood 94:2020-2028, 1999.
31. Williams AF: A year in the life of the immunoglobulin superfamily. Immunol Today 8:298-303, 1987.
32. Wong JH, Awad IA, Kim JH: Ultrastructural pathological features of cerebrovascular malformations: A preliminary report. Neurosurgery 46:1454-1459, 2000.
33. Yang S, Graham J, Kahn JW, Schwartz EA, Gerritsen ME: Functional roles for PECAM-1 (CD31) and VE- cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels. Am J Pathol 155:887-895, 1999.